Table 3.
Comparison of changes in quality-of-life scores at 3 and 6 months postoperative
| At 3 months | At 6 months | |||||
|---|---|---|---|---|---|---|
| Myomectomy n = 34 Difference from baseline |
Myolysis n = 16 Difference from baseline | P value | Myomectomy n = 34 Difference from baseline | Myolysis n = 16 Difference from baseline | p value | |
| UFS-QOL questionnaire | ||||||
| SSS | − 23.3 ± 33 | − 27.5 ± 31.5 | 0.66 | − 32.8 ± 29.8 | − 15.8 ± 22.6 | 0.03* |
| HRQOL total score | 24.2 ± 28.2 | 9.2 ± 34.3 | 0.14 | 29.4 ± 28.3 | 13.0 ± 29.7 | 0.08 |
| EQ-5D questionnaire | ||||||
| Visual analog scale | 17.4 ± 19.1 | 6.6 ± 24.3 | 0.13 | 16.5 ± 33.1 | 11.6 ± 27.6 | 0.58 |
| FSFI questionnaire | ||||||
| FSS | − 1.5 ± 10.8 | 0.9 ± 14.7 | 0.40 | 1.3 ± 10.9 | 3.4 ± 10 | 0.40 |
The data are presented as means ± standard deviation (SD). The effects of time were adjusted for the following confounding variables: age, gravidity, initial fibroid-specific quality-of-life score, size of the largest fibroid, history of myomectomy, and metrorrhagia
SSS Symptom Severity Score; higher transformed scores indicate greater severity or discomfort of symptoms, HRQOL Health-Related Quality of Life; higher transformed scores indicate greater quality of life, FSS full scale score
p values were calculated to compare the differences in scores over time (*p < 0.05—statistically significant)